AAAAAA

   
Results: 1-15 |
Results: 15
Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor
Authors: Kwasny, W Kornek, G Haider, K Valencak, J Ulrich-Pur, H Penz, M Lang, F Depisch, D Scheithauer, W
Citation: W. Kwasny et al., Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor, BREAST CANC, 63(3), 2000, pp. 235-241
Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma
Authors: Valencak, J Dietrich, W Raderer, M Dieckmann, K Prayer, D Hainfellner, JA Marosi, C
Citation: J. Valencak et al., Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma, J NEURO-ONC, 49(3), 2000, pp. 263-268
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori
Authors: Raderer, M Pfeffel, F Pohl, G Mannhalter, C Valencak, J Chott, A
Citation: M. Raderer et al., Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori, GUT, 46(1), 2000, pp. 133-135
Chemotherapy for the treatment of patients with primary high grade gastricB-cell lymphoma of modified Ann Arbor Stages IE and IIE
Authors: Raderer, M Valencak, J Osterreicher, C Drach, J Hejna, M Kornek, G Scheithauer, W Brodowicz, T Chott, A Dragosics, B
Citation: M. Raderer et al., Chemotherapy for the treatment of patients with primary high grade gastricB-cell lymphoma of modified Ann Arbor Stages IE and IIE, CANCER, 88(9), 2000, pp. 1979-1985
Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma
Authors: Raderer, M Vorbeck, F Formanek, M Osterreicher, C Valencak, J Penz, M Kornek, G Hamilton, G Dragosics, B Chott, A
Citation: M. Raderer et al., Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma, BR J CANC, 83(4), 2000, pp. 454-457
Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type
Authors: Raderer, M Valencak, J Pfeffel, F Drach, J Pangerl, T Kurtaran, A Hejna, M Vorbeck, F Chott, A Virgolini, I
Citation: M. Raderer et al., Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type, J NAT CANC, 91(8), 1999, pp. 716-718
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer
Authors: Scheithauer, W Kornek, GV Raderer, M Valencak, J Weinlander, G Hejna, M Haider, K Kwasny, W Depisch, D
Citation: W. Scheithauer et al., Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer, J CL ONCOL, 17(3), 1999, pp. 902-906
Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens
Authors: Valencak, J Kornek, GV Raderer, M Ulrich-Pur, H Krauss, G Greul, R Pidlich, J Pfeffel, F Haider, K Kwasny, W Schneeweiss, B Scheithauer, W
Citation: J. Valencak et al., Gemcitabine for the treatment of advanced biliary tract carcinomas: Evaluation of two different dose regimens, ONKOLOGIE, 22(6), 1999, pp. 498-501
The nerve of Henle: An anatomic and immunohistochemical study
Authors: Balogh, B Valencak, J Vesely, M Flammer, M Gruber, H Piza-Katzer, H
Citation: B. Balogh et al., The nerve of Henle: An anatomic and immunohistochemical study, J HAND S-AM, 24A(5), 1999, pp. 1103-1108
Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor
Authors: Haider, K Kornek, GV Kwasny, W Weinlander, G Valencak, J Lang, F Puribauer, F Kovats, E Depisch, D Scheithauer, W
Citation: K. Haider et al., Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor, BREAST CANC, 55(3), 1999, pp. 203-211
Anal pruritus after cancer chemotherapy with gemcitabine
Authors: Hejna, M Valencak, J Raderer, M
Citation: M. Hejna et al., Anal pruritus after cancer chemotherapy with gemcitabine, N ENG J MED, 340(8), 1999, pp. 655-656
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma
Authors: Scheithauer, W Kornek, GV Raderer, M Hejna, M Valencak, J Miholic, J Kovats, E Lang, F Funovics, J Bareck, E Depisch, D
Citation: W. Scheithauer et al., Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma, BR J CANC, 80(11), 1999, pp. 1797-1802
Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
Authors: Raderer, M Hamilton, G Kurtaran, A Valencak, J Haberl, I Hoffmann, O Kornek, GV Vorbeck, F Hejna, MHL Virgolini, I Scheithauer, W
Citation: M. Raderer et al., Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results, BR J CANC, 79(3-4), 1999, pp. 535-537
5-Methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: A randomized phase I-II study of two different FU administration schedules
Authors: Hejna, M Kornek, GV Raderer, M Valencak, J Weinlander, G Fiebiger, W Miholic, J Scheithauer, W
Citation: M. Hejna et al., 5-Methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: A randomized phase I-II study of two different FU administration schedules, ANN ONCOL, 9(12), 1998, pp. 1309-1314
Status of modern radioimaging methods in diagnosis and staging of gastrointestinal malignancies
Authors: Valencak, J Raderer, M
Citation: J. Valencak et M. Raderer, Status of modern radioimaging methods in diagnosis and staging of gastrointestinal malignancies, ONKOLOGIE, 21(5), 1998, pp. 434-437
Risultati: 1-15 |